샘플 요청 목록

 카트 문의
시장보고서
상품코드
1794771

세계의 정형외과 임플란트용 황색포도구균 감염증 진단 및 치료 시장

Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 278 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

정형외과 임플란트용 황색포도구균 감염증 진단 및 치료 세계 시장은 2030년까지 30억 달러에 달할 전망

2024년에 24억 달러로 추정되는 정형외과 임플란트용 황색포도구균 감염증 진단 및 치료 세계 시장은 2024년부터 2030년까지 CAGR 3.2%로 성장하여 2030년에는 30억 달러에 달할 것으로 예측됩니다. 이 보고서에서 분석한 부문 중 하나인 진단은 CAGR 2.4%를 기록하며 분석 기간 종료까지 17억 달러에 달할 것으로 예측됩니다. 치료 분야의 성장률은 분석 기간 동안 CAGR 4.5%로 추정됩니다.

미국 시장은 6억 6,610만 달러로 추정, 중국은 CAGR 5.9%로 성장 예측

미국의 정형외과 임플란트용 황색포도구균 감염증 진단 및 치료 시장은 2024년에 6억 6,610만 달러로 추정됩니다. 세계 2위 경제 대국인 중국은 2030년까지 5억 7,950만 달러의 시장 규모에 달할 것으로 예측되며, 분석 기간인 2024-2030년 CAGR은 5.9%를 기록할 것으로 예상됩니다. 기타 주목할 만한 지역별 시장으로는 일본과 캐나다가 있고, 분석 기간 동안 CAGR은 각각 1.3%와 2.4%로 예측됩니다. 유럽에서는 독일이 CAGR 1.8%로 성장할 것으로 예측됩니다.

세계의 정형외과 임플란트용 황색포도구균 감염증 진단 및 치료 시장 - 주요 동향과 촉진요인 정리

정형외과용 임플란트에서 황색포도상구균 검출의 발전 원동력은 무엇인가?

황색포도상구균(S. aureus), 특히 메티실린 내성균(MRSA)은 정형외과 임플란트에서 인공관절 주위 감염(PJI)의 주요 원인입니다. 이러한 감염은 임플란트 파손, 골수염, 패혈증 등 심각한 합병증을 유발할 수 있습니다. 신속하고 정확한 발견과 표적화된 치료는 임상 결과에 매우 중요합니다. 기존의 진단은 미생물 배양에 의존했지만, 배양에 시간이 오래 걸리고 위음성을 나타내는 경우가 많았습니다. 오늘날 PCR, 차세대 염기서열 분석(NGS), 면역분석과 같은 분자진단법을 통해 황색포도상구균 및 관련 생물막 형성 병원균을 조기에 안정적으로 검출할 수 있게 되었습니다.

FDG-PET, WBC 표지 SPECT/CT와 같은 첨단 영상 진단법도 감염의 국소화를 확인하기 위해 사용되고 있습니다. 내성 유전자(mecA 등)를 검출할 수 있는 POC(Point-of-Care) 바이오센서나 멀티플렉스 패널도 임상 적용되고 있습니다. 이러한 도구는 정형외과 의사나 감염 전문의가 정보에 입각한 데브리드맨과 항생제를 보다 신속하게 선택할 수 있도록 돕고 있습니다.

새로운 치료법과 코팅이 임플란트 식립 후 관리를 변화시킬 것인가?

은 나노입자, 항생제 함유 시멘트, 요오드 활성화 표면 등 항균 코팅의 혁신은 진단에 그치지 않고 임플란트의 바이오필름 형성을 방지하는 데에도 활용되고 있습니다. 병원균의 유전자 프로파일링에 기반한 맞춤형 항생제 요법은 제균율을 향상시키고 있습니다. 장시간 작용하는 항생제 캐리어(비드, 스페이서)는 전신 독성 없이 국소적인 약물전달을 가능하게 합니다.

세라믹 접근법(진단과 치료가 하나의 임플란트나 코팅에 결합된 것)은 수술 중 적용이 검토되고 있습니다. 면역요법이나 파지 기반의 항균요법은 보다 특이적으로 항생제 내성 균주를 타겟으로 한 임상 개발이 진행되고 있습니다.

정형외과 전문의가 조기 치료에 집중하는 이유는?

전 세계적으로 슬관절, 고관절, 척추 임플란트 사용량이 증가함에 따라 감염 예방과 대책이 최우선 과제로 대두되고 있습니다. 황색포도상구균 감염은 재수술률, 입원기간, 비용을 크게 증가시킵니다. 외과의사는 불필요한 제거를 피하기 위해 수술 중 실시간으로 병원균을 식별할 수 있는 도구를 원하고 있습니다. 병원은 수술 전 검사, 수술 중 진단, 수술 후 감시를 포함한 종합적인 감염 관리 프로토콜을 채택하고 있습니다.

정형외과용 황색포도상구균 감염증 시장의 성장 원동력은?

이 시장의 성장은 정형외과 수술 건수, 진단 기술 혁신, 내성 동향과 관련된 여러 요인에 의해 이루어집니다. 전 세계적으로 인공관절 치환술이 증가함에 따라 임플란트 관련 감염의 위험과 발생률이 증가하고 있습니다. 신속 분자진단 및 바이오필름 영상화 도구의 기술 발전으로 임상적 검출률이 향상되고 있습니다. 새로운 항균 소재와 국소 약물전달 시스템은 치료의 선택권을 넓혀주고 있습니다. 마지막으로, 항생제 내성의 확산은 새로운 치료법에 대한 투자를 촉진하고 정형외과 환경에서 정밀하고 적극적인 감염 관리 솔루션에 대한 수요를 창출하고 있습니다.

부문

구성요소(진단, 치료), 최종사용(병원 최종사용, 외래 수술 센터 최종사용, 기타 최종사용)

조사 대상 기업 사례

  • Abbott Laboratories
  • Beckman Coulter Inc.
  • Becton Dickinson(BD)
  • BioMerieux SA
  • C2Dx, Inc.
  • Cepheid
  • Hologic(Molecular Diagnostics)
  • Johnson & Johnson MedTech
  • MediWound
  • Merck KGaA
  • Micreos(Staphefekt)
  • Ortho Clinical Diagnostics
  • Pfizer Inc.
  • Roche(Roche Diagnostics)
  • Sabiad
  • Schwitz Biotech
  • Siemens Healthineers
  • Stryker Corporation
  • Thermo Fisher Scientific Inc.
  • Wellona Pharma

AI 통합

Global Industry Analysts는 검증된 전문가 컨텐츠와 AI 툴을 통해 시장 정보와 경쟁 정보를 혁신하고 있습니다.

Global Industry Analysts는 일반적인 LLM 및 업계별 SLM 쿼리를 따르는 대신 비디오 기록, 블로그, 검색 엔진 조사, 방대한 양의 기업, 제품/서비스, 시장 데이터 등 세계 전문가로부터 수집한 컨텐츠 리포지토리를 구축했습니다.

관세 영향 계수

Global Industry Analysts는 본사 소재지, 제조거점, 수출입(완제품 및 OEM)을 기준으로 기업의 경쟁력 변화를 예측하고 있습니다. 이러한 복잡하고 다면적인 시장 역학은 매출원가(COGS) 증가, 수익성 하락, 공급망 재편 등 미시적, 거시적 시장 역학 중에서도 특히 경쟁사들에게 영향을 미칠 것으로 예상됩니다.

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트
  • 기타 중동
  • 아프리카

제4장 경쟁

KSM 25.08.28

Global Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants Market to Reach US$3.0 Billion by 2030

The global market for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants estimated at US$2.4 Billion in the year 2024, is expected to reach US$3.0 Billion by 2030, growing at a CAGR of 3.2% over the analysis period 2024-2030. Diagnosis, one of the segments analyzed in the report, is expected to record a 2.4% CAGR and reach US$1.7 Billion by the end of the analysis period. Growth in the Treatment segment is estimated at 4.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$666.1 Million While China is Forecast to Grow at 5.9% CAGR

The Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants market in the U.S. is estimated at US$666.1 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$579.5 Million by the year 2030 trailing a CAGR of 5.9% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.3% and 2.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 1.8% CAGR.

Global Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants Market - Key Trends & Drivers Summarized

What’s Driving Advances in Staphylococcus Aureus Detection in Orthopedic Implants?

Staphylococcus aureus (S. aureus), particularly its methicillin-resistant strain (MRSA), is a major cause of periprosthetic joint infections (PJI) in orthopedic implants. These infections can lead to severe complications, including implant failure, osteomyelitis, and sepsis. Rapid, accurate detection and targeted treatment are critical for clinical outcomes. Conventional diagnosis relied on microbial culture, which is slow and often yields false negatives. Today, molecular diagnostics-like PCR, next-generation sequencing (NGS), and immunoassays-are enabling earlier and more reliable detection of S. aureus and associated biofilm-forming pathogens.

Advanced imaging modalities, such as FDG-PET and WBC-labeled SPECT/CT, are also being used to localize infections. Point-of-care biosensors and multiplexed panels capable of detecting resistance genes (e.g., mecA) are entering clinical use. These tools help orthopedic surgeons and infectious disease specialists make informed debridement and antibiotic choices more quickly.

Are Novel Therapies and Coatings Transforming Post-Implant Management?

Beyond diagnostics, innovations in antimicrobial coatings-silver nanoparticles, antibiotic-loaded cements, and iodine-activated surfaces-are being employed to prevent biofilm formation on implants. Personalized antibiotic regimens based on genetic profiling of pathogens are improving eradication rates. Long-acting antibiotic carriers (beads, spacers) provide localized drug delivery without systemic toxicity.

Theranostic approaches-where diagnosis and therapy are combined in a single implant or coating-are being explored for intraoperative applications. Immunotherapies and phage-based antibacterial therapies are under clinical development, targeting antibiotic-resistant strains with greater specificity.

Why Are Orthopedic Specialists Focusing on Early Intervention?

As the global volume of knee, hip, and spinal implants rises, infection prevention and control have become top priorities. S. aureus infections significantly increase revision rates, hospitalization duration, and costs. Surgeons are demanding tools that enable real-time pathogen identification during surgery to avoid unnecessary explantation. Hospitals are adopting comprehensive infection management protocols-including preoperative screening, intraoperative diagnostics, and post-op surveillance.

What’s Powering the Growth in the Orthopedic S. Aureus Infection Market?

The growth in this market is driven by several factors related to orthopedic surgery volumes, diagnostic innovation, and resistance trends. The rise in joint replacement procedures globally is increasing risk and incidence of implant-related infections. Technological advancements in rapid molecular diagnostics and biofilm imaging tools are improving clinical detection rates. New antimicrobial materials and localized drug-delivery systems are expanding treatment options. Finally, the spread of antibiotic resistance is fueling investment in novel therapies, creating demand for precise and aggressive infection control solutions in orthopedic settings.

SCOPE OF STUDY:

The report analyzes the Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Component (Diagnosis, Treatment); End-Use (Hospitals End-Use, Ambulatory Surgery Centers End-Use, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 44 Featured) -

  • Abbott Laboratories
  • Beckman Coulter Inc.
  • Becton Dickinson (BD)
  • BioMerieux SA
  • C2Dx, Inc.
  • Cepheid
  • Hologic (Molecular Diagnostics)
  • Johnson & Johnson MedTech
  • MediWound
  • Merck KGaA
  • Micreos (Staphefekt)
  • Ortho Clinical Diagnostics
  • Pfizer Inc.
  • Roche (Roche Diagnostics)
  • Sabiad
  • Schwitz Biotech
  • Siemens Healthineers
  • Stryker Corporation
  • Thermo Fisher Scientific Inc.
  • Wellona Pharma

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Tariff Impact on Global Supply Chain Patterns
    • Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Incidence of Post-Operative Infections Drives Demand for Advanced Diagnostic Solutions
    • Increase in Joint Replacement and Trauma Surgeries Spurs Need for S. aureus Monitoring
    • Growing Focus on Implant-Associated Infections Throws Spotlight on Early Detection Technologies
    • Development of Rapid Molecular Diagnostics Enhances Clinical Decision-Making
    • Antimicrobial Coating Innovations Strengthen Business Case for Preventative Orthopedic Implants
    • Regulatory Guidelines for Surgical Site Infections Drive Compliance-Based Adoption
    • AI and Machine Learning in Diagnostic Algorithms Accelerate Infection Identification Accuracy
    • Expansion of Outpatient Orthopedic Care Creates Demand for Point-of-Care Testing Kits
    • Rise in Antibiotic Resistance Fuels R&D in Novel Therapeutics and Diagnostic Pathways
    • Healthcare Cost Containment Strategies Encourage Early Diagnosis and Treatment
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 4: World 16-Year Perspective for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Diagnosis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Diagnosis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 7: World 16-Year Perspective for Diagnosis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 10: World 16-Year Perspective for Treatment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 13: World 16-Year Perspective for Hospitals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Ambulatory Surgery Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 16: World 16-Year Perspective for Ambulatory Surgery Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 19: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 20: USA Recent Past, Current & Future Analysis for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Diagnosis and Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 21: USA Historic Review for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Diagnosis and Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 22: USA 16-Year Perspective for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Percentage Breakdown of Value Sales for Diagnosis and Treatment for the Years 2014, 2025 & 2030
    • TABLE 23: USA Recent Past, Current & Future Analysis for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 25: USA 16-Year Perspective for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • CANADA
    • TABLE 26: Canada Recent Past, Current & Future Analysis for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Diagnosis and Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 27: Canada Historic Review for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Diagnosis and Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 28: Canada 16-Year Perspective for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Percentage Breakdown of Value Sales for Diagnosis and Treatment for the Years 2014, 2025 & 2030
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 31: Canada 16-Year Perspective for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • JAPAN
    • Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 32: Japan Recent Past, Current & Future Analysis for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Diagnosis and Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Japan Historic Review for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Diagnosis and Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 34: Japan 16-Year Perspective for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Percentage Breakdown of Value Sales for Diagnosis and Treatment for the Years 2014, 2025 & 2030
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 37: Japan 16-Year Perspective for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • CHINA
    • Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 38: China Recent Past, Current & Future Analysis for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Diagnosis and Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: China Historic Review for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Diagnosis and Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 40: China 16-Year Perspective for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Percentage Breakdown of Value Sales for Diagnosis and Treatment for the Years 2014, 2025 & 2030
    • TABLE 41: China Recent Past, Current & Future Analysis for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 43: China 16-Year Perspective for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • EUROPE
    • Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 44: Europe Recent Past, Current & Future Analysis for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 45: Europe Historic Review for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 46: Europe 16-Year Perspective for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Diagnosis and Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Diagnosis and Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 49: Europe 16-Year Perspective for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Percentage Breakdown of Value Sales for Diagnosis and Treatment for the Years 2014, 2025 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 52: Europe 16-Year Perspective for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • FRANCE
    • Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 53: France Recent Past, Current & Future Analysis for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Diagnosis and Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: France Historic Review for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Diagnosis and Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 55: France 16-Year Perspective for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Percentage Breakdown of Value Sales for Diagnosis and Treatment for the Years 2014, 2025 & 2030
    • TABLE 56: France Recent Past, Current & Future Analysis for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 58: France 16-Year Perspective for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • GERMANY
    • Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 59: Germany Recent Past, Current & Future Analysis for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Diagnosis and Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Germany Historic Review for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Diagnosis and Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 61: Germany 16-Year Perspective for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Percentage Breakdown of Value Sales for Diagnosis and Treatment for the Years 2014, 2025 & 2030
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 64: Germany 16-Year Perspective for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • ITALY
    • TABLE 65: Italy Recent Past, Current & Future Analysis for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Diagnosis and Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Italy Historic Review for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Diagnosis and Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 67: Italy 16-Year Perspective for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Percentage Breakdown of Value Sales for Diagnosis and Treatment for the Years 2014, 2025 & 2030
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 70: Italy 16-Year Perspective for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • UNITED KINGDOM
    • Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 71: UK Recent Past, Current & Future Analysis for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Diagnosis and Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: UK Historic Review for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Diagnosis and Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 73: UK 16-Year Perspective for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Percentage Breakdown of Value Sales for Diagnosis and Treatment for the Years 2014, 2025 & 2030
    • TABLE 74: UK Recent Past, Current & Future Analysis for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 76: UK 16-Year Perspective for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • SPAIN
    • TABLE 77: Spain Recent Past, Current & Future Analysis for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Diagnosis and Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Spain Historic Review for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Diagnosis and Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 79: Spain 16-Year Perspective for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Percentage Breakdown of Value Sales for Diagnosis and Treatment for the Years 2014, 2025 & 2030
    • TABLE 80: Spain Recent Past, Current & Future Analysis for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Spain Historic Review for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 82: Spain 16-Year Perspective for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • RUSSIA
    • TABLE 83: Russia Recent Past, Current & Future Analysis for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Diagnosis and Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Russia Historic Review for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Diagnosis and Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 85: Russia 16-Year Perspective for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Percentage Breakdown of Value Sales for Diagnosis and Treatment for the Years 2014, 2025 & 2030
    • TABLE 86: Russia Recent Past, Current & Future Analysis for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Russia Historic Review for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 88: Russia 16-Year Perspective for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • REST OF EUROPE
    • TABLE 89: Rest of Europe Recent Past, Current & Future Analysis for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Diagnosis and Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Rest of Europe Historic Review for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Diagnosis and Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 91: Rest of Europe 16-Year Perspective for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Percentage Breakdown of Value Sales for Diagnosis and Treatment for the Years 2014, 2025 & 2030
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Rest of Europe Historic Review for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 94: Rest of Europe 16-Year Perspective for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • ASIA-PACIFIC
    • Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 95: Asia-Pacific Recent Past, Current & Future Analysis for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 96: Asia-Pacific Historic Review for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 97: Asia-Pacific 16-Year Perspective for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Diagnosis and Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Diagnosis and Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 100: Asia-Pacific 16-Year Perspective for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Percentage Breakdown of Value Sales for Diagnosis and Treatment for the Years 2014, 2025 & 2030
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 103: Asia-Pacific 16-Year Perspective for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • AUSTRALIA
    • Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 104: Australia Recent Past, Current & Future Analysis for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Diagnosis and Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Australia Historic Review for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Diagnosis and Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 106: Australia 16-Year Perspective for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Percentage Breakdown of Value Sales for Diagnosis and Treatment for the Years 2014, 2025 & 2030
    • TABLE 107: Australia Recent Past, Current & Future Analysis for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Australia Historic Review for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 109: Australia 16-Year Perspective for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • INDIA
    • Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 110: India Recent Past, Current & Future Analysis for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Diagnosis and Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: India Historic Review for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Diagnosis and Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 112: India 16-Year Perspective for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Percentage Breakdown of Value Sales for Diagnosis and Treatment for the Years 2014, 2025 & 2030
    • TABLE 113: India Recent Past, Current & Future Analysis for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: India Historic Review for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 115: India 16-Year Perspective for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • SOUTH KOREA
    • TABLE 116: South Korea Recent Past, Current & Future Analysis for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Diagnosis and Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: South Korea Historic Review for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Diagnosis and Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 118: South Korea 16-Year Perspective for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Percentage Breakdown of Value Sales for Diagnosis and Treatment for the Years 2014, 2025 & 2030
    • TABLE 119: South Korea Recent Past, Current & Future Analysis for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: South Korea Historic Review for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 121: South Korea 16-Year Perspective for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 122: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Diagnosis and Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Rest of Asia-Pacific Historic Review for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Diagnosis and Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 124: Rest of Asia-Pacific 16-Year Perspective for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Percentage Breakdown of Value Sales for Diagnosis and Treatment for the Years 2014, 2025 & 2030
    • TABLE 125: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Rest of Asia-Pacific Historic Review for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 127: Rest of Asia-Pacific 16-Year Perspective for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • LATIN AMERICA
    • Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 128: Latin America Recent Past, Current & Future Analysis for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 129: Latin America Historic Review for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 130: Latin America 16-Year Perspective for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
    • TABLE 131: Latin America Recent Past, Current & Future Analysis for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Diagnosis and Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Latin America Historic Review for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Diagnosis and Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 133: Latin America 16-Year Perspective for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Percentage Breakdown of Value Sales for Diagnosis and Treatment for the Years 2014, 2025 & 2030
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 136: Latin America 16-Year Perspective for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • ARGENTINA
    • TABLE 137: Argentina Recent Past, Current & Future Analysis for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Diagnosis and Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Argentina Historic Review for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Diagnosis and Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 139: Argentina 16-Year Perspective for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Percentage Breakdown of Value Sales for Diagnosis and Treatment for the Years 2014, 2025 & 2030
    • TABLE 140: Argentina Recent Past, Current & Future Analysis for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Argentina Historic Review for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 142: Argentina 16-Year Perspective for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • BRAZIL
    • TABLE 143: Brazil Recent Past, Current & Future Analysis for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Diagnosis and Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Brazil Historic Review for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Diagnosis and Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 145: Brazil 16-Year Perspective for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Percentage Breakdown of Value Sales for Diagnosis and Treatment for the Years 2014, 2025 & 2030
    • TABLE 146: Brazil Recent Past, Current & Future Analysis for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Brazil Historic Review for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 148: Brazil 16-Year Perspective for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • MEXICO
    • TABLE 149: Mexico Recent Past, Current & Future Analysis for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Diagnosis and Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Mexico Historic Review for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Diagnosis and Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 151: Mexico 16-Year Perspective for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Percentage Breakdown of Value Sales for Diagnosis and Treatment for the Years 2014, 2025 & 2030
    • TABLE 152: Mexico Recent Past, Current & Future Analysis for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Mexico Historic Review for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 154: Mexico 16-Year Perspective for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 155: Rest of Latin America Recent Past, Current & Future Analysis for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Diagnosis and Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Rest of Latin America Historic Review for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Diagnosis and Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 157: Rest of Latin America 16-Year Perspective for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Percentage Breakdown of Value Sales for Diagnosis and Treatment for the Years 2014, 2025 & 2030
    • TABLE 158: Rest of Latin America Recent Past, Current & Future Analysis for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Rest of Latin America Historic Review for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 160: Rest of Latin America 16-Year Perspective for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • MIDDLE EAST
    • Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 161: Middle East Recent Past, Current & Future Analysis for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 162: Middle East Historic Review for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 163: Middle East 16-Year Perspective for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
    • TABLE 164: Middle East Recent Past, Current & Future Analysis for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Diagnosis and Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Middle East Historic Review for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Diagnosis and Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 166: Middle East 16-Year Perspective for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Percentage Breakdown of Value Sales for Diagnosis and Treatment for the Years 2014, 2025 & 2030
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 169: Middle East 16-Year Perspective for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • IRAN
    • TABLE 170: Iran Recent Past, Current & Future Analysis for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Diagnosis and Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Iran Historic Review for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Diagnosis and Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 172: Iran 16-Year Perspective for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Percentage Breakdown of Value Sales for Diagnosis and Treatment for the Years 2014, 2025 & 2030
    • TABLE 173: Iran Recent Past, Current & Future Analysis for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Iran Historic Review for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 175: Iran 16-Year Perspective for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • ISRAEL
    • TABLE 176: Israel Recent Past, Current & Future Analysis for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Diagnosis and Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Israel Historic Review for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Diagnosis and Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 178: Israel 16-Year Perspective for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Percentage Breakdown of Value Sales for Diagnosis and Treatment for the Years 2014, 2025 & 2030
    • TABLE 179: Israel Recent Past, Current & Future Analysis for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Israel Historic Review for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 181: Israel 16-Year Perspective for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 182: Saudi Arabia Recent Past, Current & Future Analysis for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Diagnosis and Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Saudi Arabia Historic Review for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Diagnosis and Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 184: Saudi Arabia 16-Year Perspective for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Percentage Breakdown of Value Sales for Diagnosis and Treatment for the Years 2014, 2025 & 2030
    • TABLE 185: Saudi Arabia Recent Past, Current & Future Analysis for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Saudi Arabia Historic Review for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 187: Saudi Arabia 16-Year Perspective for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 188: UAE Recent Past, Current & Future Analysis for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Diagnosis and Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: UAE Historic Review for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Diagnosis and Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 190: UAE 16-Year Perspective for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Percentage Breakdown of Value Sales for Diagnosis and Treatment for the Years 2014, 2025 & 2030
    • TABLE 191: UAE Recent Past, Current & Future Analysis for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: UAE Historic Review for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 193: UAE 16-Year Perspective for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 194: Rest of Middle East Recent Past, Current & Future Analysis for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Diagnosis and Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Rest of Middle East Historic Review for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Diagnosis and Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 196: Rest of Middle East 16-Year Perspective for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Percentage Breakdown of Value Sales for Diagnosis and Treatment for the Years 2014, 2025 & 2030
    • TABLE 197: Rest of Middle East Recent Past, Current & Future Analysis for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Rest of Middle East Historic Review for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 199: Rest of Middle East 16-Year Perspective for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • AFRICA
    • Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 200: Africa Recent Past, Current & Future Analysis for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Diagnosis and Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Africa Historic Review for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Diagnosis and Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 202: Africa 16-Year Perspective for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Percentage Breakdown of Value Sales for Diagnosis and Treatment for the Years 2014, 2025 & 2030
    • TABLE 203: Africa Recent Past, Current & Future Analysis for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Africa Historic Review for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 205: Africa 16-Year Perspective for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제